{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:14:02Z","timestamp":1757780042157,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Children's Orthopaedic Surgery Foundation"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR053237"],"award-info":[{"award-number":["AR053237"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bone.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:31:44Z","timestamp":1505953904000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Clcn7F318L\/+ as a new mouse model of Albers-Sch\u00f6nberg disease"],"prefix":"10.1016","volume":"105","author":[{"given":"J.","family":"Caetano-Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.G.","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.S.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Horan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.R.","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.","family":"Robling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2020-3449","authenticated-orcid":false,"given":"M.L.","family":"Warman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.bone.2017.09.007_bb0005","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMra040952","article-title":"Osteopetrosis","volume":"351","author":"Tolar","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bone.2017.09.007_bb0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1399-0004.1987.tb02774.x","article-title":"Osteopetrosis. A genetic and epidemiological study","volume":"31","author":"Bollerslev","year":"1987","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.bone.2017.09.007_bb0015","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-13-0136","article-title":"Autosomal dominant osteopetrosis revisited: lessons from recent studies","volume":"169","author":"Bollerslev","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2017.09.007_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-4-5","article-title":"Osteopetrosis","volume":"4","author":"Stark","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2017.09.007_bb0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2017.02.002","article-title":"Osteopetroses, emphasizing potential approaches to treatment","volume":"102","author":"Teti","year":"2017","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bone.2017.09.007_bb0030","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/emboj.2011.137","article-title":"ClC-7 is a slowly voltage-gated 2Cl(\u2212)\/1H(+)-exchanger and requires Ostm1 for transport activity","volume":"30","author":"Leisle","year":"2011","journal-title":"EMBO J."},{"issue":"7196","key":"10.1016\/j.bone.2017.09.007_bb0035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature06907","article-title":"The Cl\u2212\/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes","volume":"453","author":"Graves","year":"2008","journal-title":"Nature"},{"issue":"40","key":"10.1016\/j.bone.2017.09.007_bb0040","doi-asserted-by":"crossref","first-page":"28611","DOI":"10.1074\/jbc.M113.509364","article-title":"Common gating of both CLC transporter subunits underlies voltage-dependent activation of the 2Cl\u2212\/1H+ exchanger ClC-7\/Ostm1","volume":"288","author":"Ludwig","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bone.2017.09.007_bb0045","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2017.09.007_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bone.2013.10.021","article-title":"Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models","volume":"59","author":"Alam","year":"2014","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2017.09.007_bb0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.09.007_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2016.10.016","article-title":"Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease","volume":"94","author":"Alam","year":"2017","journal-title":"Bone"},{"issue":"24","key":"10.1016\/j.bone.2017.09.007_bb0065","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM199506153322402","article-title":"Long-term treatment of osteopetrosis with recombinant human interferon gamma","volume":"332","author":"Key","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2017.09.007_bb0070","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/jbmr.2545","article-title":"Interferon gamma, but not calcitriol improves the osteopetrotic phenotypes in ADO2 mice","volume":"30","author":"Alam","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2017.09.007_bb0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nmeth.1342","article-title":"Agouti C57BL\/6N embryonic stem cells for mouse genetic resources","volume":"6","author":"Pettitt","year":"2009","journal-title":"Nat. Methods"},{"issue":"9","key":"10.1016\/j.bone.2017.09.007_bb0080","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1073\/pnas.96.9.5037","article-title":"Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice","volume":"96","author":"Mao","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bone.2017.09.007_bb0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2144\/00291bm09","article-title":"Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT)","volume":"29","author":"Truett","year":"2000","journal-title":"Biotechniques"},{"issue":"10","key":"10.1016\/j.bone.2017.09.007_bb0090","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/jbmr.2198","article-title":"Targeting the LRP5 pathway improves bone properties in a mouse model of osteogenesis imperfecta","volume":"29","author":"Jacobsen","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2017.09.007_bb0095","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","article-title":"Lrp5 functions in bone to regulate bone mass","volume":"17","author":"Cui","year":"2011","journal-title":"Nat. Med."},{"issue":"33","key":"10.1016\/j.bone.2017.09.007_bb0100","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M601000200","article-title":"The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment","volume":"281","author":"Sawakami","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bone.2017.09.007_bb0105","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2017.09.007_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2017.09.007_bb0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bone.2017.09.007_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jbmr.1717","article-title":"Sclerostin antibody improves skeletal parameters in a Brtl\/+ mouse model of osteogenesis imperfecta","volume":"28","author":"Sinder","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.09.007_bb0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bone.2016.02.018","article-title":"Scoliosis in osteogenesis imperfecta caused by COL1A1\/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment","volume":"86","author":"Sato","year":"2016","journal-title":"Bone"},{"issue":"16","key":"10.1016\/j.bone.2017.09.007_bb0130","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.jbiomech.2008.09.028","article-title":"Bisphosphonate treatment in the oim mouse model alters bone modeling during growth","volume":"41","author":"Rao","year":"2008","journal-title":"J. Biomech."},{"issue":"2","key":"10.1016\/j.bone.2017.09.007_bb0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI71101","article-title":"Evaluation of teriparatide treatment in adults with osteogenesis imperfecta","volume":"124","author":"Orwoll","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bone.2017.09.007_bb0140","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jbmr.2776","article-title":"Sclerostin antibody treatment improves the bone phenotype of Crtap(\u2212\/\u2212) mice, a model of recessive osteogenesis imperfecta","volume":"31","author":"Grafe","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2017.09.007_bb0145","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.081238","article-title":"Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation","volume":"24","author":"Uveges","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.09.007_bb0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bone.2016.06.005","article-title":"Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+\/mov13) mouse model of type I Osteogenesis Imperfecta","volume":"90","author":"Jacobsen","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.09.007_bb0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pharmthera.2016.11.009","article-title":"New horizons for cystic fibrosis treatment","volume":"170","author":"Fajac","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bone.2017.09.007_bb0160","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/8756-3282(93)90316-3","article-title":"Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis","volume":"14","author":"Bollerslev","year":"1993","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2017.09.007_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012585","article-title":"The G215R mutation in the Cl\u2212\/H+-antiporter ClC-7 found in ADO II osteopetrosis does not abolish function but causes a severe trafficking defect","volume":"5","author":"Schulz","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bone.2017.09.007_bb0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cyto.2014.10.014","article-title":"Interferon gamma in autoimmunity: a complicated player on a complex stage","volume":"74","author":"Lees","year":"2015","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.bone.2017.09.007_bb0175","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3345\/kjp.2007.50.11.1129","article-title":"Long-term recombinant interferon-\u03b3 treatment in 2 cases of osteopetrosis","volume":"50","author":"Kim","year":"2007","journal-title":"Kor. J. Pediatr."},{"issue":"7","key":"10.1016\/j.bone.2017.09.007_bb0180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/107999000414826","article-title":"IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production","volume":"20","author":"Madyastha","year":"2000","journal-title":"J. Interf. Cytokine Res."},{"issue":"1","key":"10.1016\/j.bone.2017.09.007_bb0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/00220345010800011001","article-title":"Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation","volume":"80","author":"Kamolmatyakul","year":"2001","journal-title":"J. Dent. Res."},{"issue":"5102","key":"10.1016\/j.bone.2017.09.007_bb0190","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bone.2017.09.007_bb0195","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/jbmr.350","article-title":"Interferon-gamma plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice","volume":"26","author":"Duque","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2017.09.007_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/8756-3282(89)90142-7","article-title":"Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types","volume":"10","author":"Bollerslev","year":"1989","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T06:08:15Z","timestamp":1539151695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217303447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":40,"alternative-id":["S8756328217303447"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.09.007","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clcn7F318L\/+ as a new mouse model of Albers-Sch\u00f6nberg disease","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}